Wang R - Search Results

1

Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway.

Wang R, Xu A, Zhang X, Wu J, Freywald A, Xu J, Xiang J. Wang R, et al. Cell Mol Immunol. 2017 Jun;14(6):529-545. doi: 10.1038/cmi.2016.23. Epub 2016 Jun 6. Cell Mol Immunol. 2017. PMID: 27264687 Free PMC article.

2

Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes.

Wang R, Freywald A, Chen Y, Xu J, Tan X, Xiang J. Wang R, et al. Cell Mol Immunol. 2015 Jul;12(4):456-65. doi: 10.1038/cmi.2014.72. Epub 2014 Sep 8. Cell Mol Immunol. 2015. PMID: 25195511 Free PMC article.

3

CD40 agonist converting CTL exhaustion via the activation of the mTORC1 pathway enhances PD-1 antagonist action in rescuing exhausted CTLs in chronic infection.

Xu A, Wang R, Freywald A, Stewart K, Tikoo S, Xu J, Zheng C, Xiang J. Xu A, et al. Among authors: wang r. Biochem Biophys Res Commun. 2017 Mar 11;484(3):662-667. doi: 10.1016/j.bbrc.2017.01.172. Epub 2017 Jan 31. Biochem Biophys Res Commun. 2017. PMID: 28153727

4

GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4(+) T-independent CTL responses.

Nanjundappa RH, Wang R, Xie Y, Umeshappa CS, Chibbar R, Wei Y, Liu Q, Xiang J. Nanjundappa RH, et al. Among authors: wang r. Vaccine. 2011 Apr 27;29(19):3538-47. doi: 10.1016/j.vaccine.2011.02.095. Epub 2011 Mar 12. Vaccine. 2011. PMID: 21406265

5

Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.

Nanjundappa RH, Wang R, Xie Y, Umeshappa CS, Xiang J. Nanjundappa RH, et al. Among authors: wang r. Vaccine. 2012 May 21;30(24):3519-25. doi: 10.1016/j.vaccine.2012.03.075. Epub 2012 Apr 6. Vaccine. 2012. PMID: 22484292

6

Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules.

Zeng G, Touloukian CE, Wang X, Restifo NP, Rosenberg SA, Wang RF. Zeng G, et al. Among authors: wang x, wang rf. J Immunol. 2000 Jul 15;165(2):1153-9. doi: 10.4049/jimmunol.165.2.1153. J Immunol. 2000. PMID: 10878395 Free PMC article.

7

Immunization against endogenous retroviral tumor-associated antigens.

Kershaw MH, Hsu C, Mondesire W, Parker LL, Wang G, Overwijk WW, Lapointe R, Yang JC, Wang RF, Restifo NP, Hwu P. Kershaw MH, et al. Among authors: wang g, wang rf. Cancer Res. 2001 Nov 1;61(21):7920-4. Cancer Res. 2001. PMID: 11691813 Free PMC article.

8

Human tumor antigens recognized by T lymphocytes: implications for cancer therapy.

Wang RF, Rosenberg SA. Wang RF, et al. J Leukoc Biol. 1996 Sep;60(3):296-309. doi: 10.1002/jlb.60.3.296. J Leukoc Biol. 1996. PMID: 8830785 Review.

9

Human tumor antigens: implications for cancer vaccine development.

Wang RF. Wang RF. J Mol Med (Berl). 1999 Sep;77(9):640-55. doi: 10.1007/s001099900042. J Mol Med (Berl). 1999. PMID: 10569202 Review.

10

Cancer therapy using a self-replicating RNA vaccine.

Ying H, Zaks TZ, Wang RF, Irvine KR, Kammula US, Marincola FM, Leitner WW, Restifo NP. Ying H, et al. Among authors: wang rf. Nat Med. 1999 Jul;5(7):823-7. doi: 10.1038/10548. Nat Med. 1999. PMID: 10395329 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42,263 results

Search Page

Filters